How Do We Follow Up Patients With Endometrial Cancer?

Mette Moustgaard Jeppesen*, Ole Mogensen, Dorte G. Hansen, Stinne H. Bergholdt, Pernille T. Jensen

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

PURPOSE OF REVIEW: In this review, we present the existing evidence regarding follow-up care after endometrial cancer, including content of follow-up and type of provider. We furthermore discuss the future perspectives for follow-up care and research in the field.

RECENT FINDINGS: Recently published randomized controlled trials show that nurse-led telephone follow-up and patient-initiated follow-up are feasible alternatives to routine hospital-based follow-up. No randomized or prospective study has evaluated the effect of routine follow-up on survival. Hence, current knowledge is derived from retrospective studies with the inherent risk of bias. The most important method for recurrence detection is a review of symptoms. There is no evidence to support a survival benefit from the use of routine physical examinations, additional tests, or imaging. One in three of the women attending hospital-based follow-up experience unmet needs, and alternative models for follow-up focused on survivorship care and empowerment should be tested.

OriginalsprogEngelsk
Artikelnummer57
TidsskriftCurrent Oncology Reports
Vol/bind21
Udgave nummer7
Antal sider8
ISSN1523-3790
DOI
StatusUdgivet - 15. maj 2019

Fingeraftryk

Endometrial Neoplasms
Physical Examination
Survival Rate
Randomized Controlled Trials
Retrospective Studies
Nurses
Prospective Studies
Research
Power (Psychology)

Citer dette

Jeppesen, Mette Moustgaard ; Mogensen, Ole ; Hansen, Dorte G. ; Bergholdt, Stinne H. ; Jensen, Pernille T. / How Do We Follow Up Patients With Endometrial Cancer?. I: Current Oncology Reports. 2019 ; Bind 21, Nr. 7.
@article{2082b3e2b479448baafeac7d1990d31c,
title = "How Do We Follow Up Patients With Endometrial Cancer?",
abstract = "PURPOSE OF REVIEW: In this review, we present the existing evidence regarding follow-up care after endometrial cancer, including content of follow-up and type of provider. We furthermore discuss the future perspectives for follow-up care and research in the field.RECENT FINDINGS: Recently published randomized controlled trials show that nurse-led telephone follow-up and patient-initiated follow-up are feasible alternatives to routine hospital-based follow-up. No randomized or prospective study has evaluated the effect of routine follow-up on survival. Hence, current knowledge is derived from retrospective studies with the inherent risk of bias. The most important method for recurrence detection is a review of symptoms. There is no evidence to support a survival benefit from the use of routine physical examinations, additional tests, or imaging. One in three of the women attending hospital-based follow-up experience unmet needs, and alternative models for follow-up focused on survivorship care and empowerment should be tested.",
keywords = "Endometrial cancer, Follow-up, Post-treatment surveillance, Recurrence, gynecologic malignancy",
author = "Jeppesen, {Mette Moustgaard} and Ole Mogensen and Hansen, {Dorte G.} and Bergholdt, {Stinne H.} and Jensen, {Pernille T.}",
year = "2019",
month = "5",
day = "15",
doi = "10.1007/s11912-019-0805-3",
language = "English",
volume = "21",
journal = "Current Oncology Reports (Online)",
issn = "1534-6269",
publisher = "Springer",
number = "7",

}

How Do We Follow Up Patients With Endometrial Cancer? / Jeppesen, Mette Moustgaard; Mogensen, Ole; Hansen, Dorte G.; Bergholdt, Stinne H.; Jensen, Pernille T.

I: Current Oncology Reports, Bind 21, Nr. 7, 57, 15.05.2019.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - How Do We Follow Up Patients With Endometrial Cancer?

AU - Jeppesen, Mette Moustgaard

AU - Mogensen, Ole

AU - Hansen, Dorte G.

AU - Bergholdt, Stinne H.

AU - Jensen, Pernille T.

PY - 2019/5/15

Y1 - 2019/5/15

N2 - PURPOSE OF REVIEW: In this review, we present the existing evidence regarding follow-up care after endometrial cancer, including content of follow-up and type of provider. We furthermore discuss the future perspectives for follow-up care and research in the field.RECENT FINDINGS: Recently published randomized controlled trials show that nurse-led telephone follow-up and patient-initiated follow-up are feasible alternatives to routine hospital-based follow-up. No randomized or prospective study has evaluated the effect of routine follow-up on survival. Hence, current knowledge is derived from retrospective studies with the inherent risk of bias. The most important method for recurrence detection is a review of symptoms. There is no evidence to support a survival benefit from the use of routine physical examinations, additional tests, or imaging. One in three of the women attending hospital-based follow-up experience unmet needs, and alternative models for follow-up focused on survivorship care and empowerment should be tested.

AB - PURPOSE OF REVIEW: In this review, we present the existing evidence regarding follow-up care after endometrial cancer, including content of follow-up and type of provider. We furthermore discuss the future perspectives for follow-up care and research in the field.RECENT FINDINGS: Recently published randomized controlled trials show that nurse-led telephone follow-up and patient-initiated follow-up are feasible alternatives to routine hospital-based follow-up. No randomized or prospective study has evaluated the effect of routine follow-up on survival. Hence, current knowledge is derived from retrospective studies with the inherent risk of bias. The most important method for recurrence detection is a review of symptoms. There is no evidence to support a survival benefit from the use of routine physical examinations, additional tests, or imaging. One in three of the women attending hospital-based follow-up experience unmet needs, and alternative models for follow-up focused on survivorship care and empowerment should be tested.

KW - Endometrial cancer

KW - Follow-up

KW - Post-treatment surveillance

KW - Recurrence, gynecologic malignancy

U2 - 10.1007/s11912-019-0805-3

DO - 10.1007/s11912-019-0805-3

M3 - Review

VL - 21

JO - Current Oncology Reports (Online)

JF - Current Oncology Reports (Online)

SN - 1534-6269

IS - 7

M1 - 57

ER -